Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Conselho Nacional de Desenvolvimento Científico e Tecnológico | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Stroke is the second cause of death worldwide and the majority of the survivors remain with motor impairments. Inhibition of the motor cortex of the unaffected hemisphere has emerged as a potential intervention to enhance effects of other rehabilitation strategies on improvement of motor performance of the paretic upper limb. In this proof-of-concept study we will evaluate the effects of inhibition of the motor cortex of the unaffected hemisphere associated with robotic therapy on improvement of motor performance of the paretic upper limb in the early phase post-stroke.
The main goal of this study is to test the proof of concept of benefits of inhibition of the motor cortex of the unaffected hemisphere on learning evaluated by improvement in kinematics of motor performance, in patients with upper limb paresis in the early phase post-stroke. For this purpose, patients will be randomized to receive real or sham transcranial direct current stimulation before a session of robotic therapy. Data will be collected by kinematic assessment performed automatically by the robot at baseline, immediately after and 24h after the intervention.
The working hypothesis is that one session of upper limb motor training will lead to improvement of performance in metrics of kinematics, and this improvement will be maintained up to 24h after the end of the training.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Active stimulation + robotic therapy | Active Comparator | Active transcranial direct current stimulation will be applied during 20 minutes prior to robotic training. Number of interventions sessions: 1 |
|
| Sham stimulation + robotic therapy | Sham Comparator | Sham transcranial direct current stimulation will be applied during 20 minutes prior to robotic training. Number of interventions sessions: 1 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Robotic Therapy | Device | Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Movement Smoothness | The speed shape, calculated as mean speed divided by peak speed. | Kinematic assessment at baseline, immediately after intervention; and 24h after. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of peaks of the movement | Number of peaks of the movement is calculated as the negative of the number of peaks in the speed profile. | kinematic assessment at baseline, immediately after intervention; and 24h after. |
| Jerk metric of the movement |
Not provided
Inclusion Criteria:
Ischemic or hemorrhagic stroke onset from 3 days to 9 weeks before, confirmed by computed tomography or magnetic resonance imaging.
Motor impairment of an upper limb, defined as a score between 1 - 3 in the Medical Research Council Scale, for at lest one the following movements: elbow extension, shoulder flexion, or shoulder extension.
Ability to provide written informed consent.
Ability to comply with the schedule of interventions and evaluations in the protocol.
Exclusion Criteria:
Severe spasticity at the paretic elbow, wrist or fingers, defined as a score of > 3 in the Modified Ashworth Spasticity Scale.
No active shoulder and elbow movements
Uncontrolled medical problems such as end-stage cancer or renal disease
Pregnancy
Potential contraindications to transcranial direct current stimulation: history of seizures, lesions on the scalp, intracranial metal implants, prior intracranial surgery, use of drugs that interfere on cortical excitability (such as antiepileptic drugs, benzodiazepines)
Other neurological disorders such as Parkinson's disease
Psychiatric illness
Aphasia or severe cognitive deficits that compromise comprehension of the experimental protocol or ability to provide consent.
Hemineglect
Cerebellar lesions or on cerebellar pathways
Contact precautions
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Adriana B Conforto, D, PhD | University of Sao Paulo | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Suzana Bleckmann Reis | São Paulo | 05403900 | Brazil |
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Active stimulation | Device | Active transcranial direct current stimulation will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA). |
|
| Sham stimulation | Device | In sham transcranial direct current stimulation, no current will be delivered through the transcranial direct current stimulation device after the first 30 seconds. |
|
Jerk metric of the movement is calculated by dividing the negative mean jerk magnitude by the peak speed.
| kinematic assessment at baseline, immediately after intervention; and 24h after |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |